MPV_ICSH International Case Studies in Healthcare

Ekonomicko-správní fakulta
jaro 2025

Předmět se v období jaro 2025 nevypisuje.

0/2/0. 4 kr. Ukončení: z.
PharmDr. Martin Višňanský, MBA, Ph.D. (cvičící)
PharmDr. Martin Višňanský, MBA, Ph.D.
Katedra veřejné ekonomie – Ekonomicko-správní fakulta
Kontaktní osoba: Jana Biskupová
Dodavatelské pracoviště: Katedra veřejné ekonomie – Ekonomicko-správní fakulta
No specific prerequisites and/or co-requisites.
Omezení zápisu do předmětu
Předmět je určen pouze studentům mateřských oborů.
Mateřské obory/plány
Cíle předmětu
The aim of the subject is to present and discuss real-life, specific cases on HTA from well-defined and precisely selected stakeholders and resources, e.g. NICE, EUnetHTA Databases, Value in Health, Int J TA in HC, etc.
Students will gain broader knowledge on the process of assessment and appraisal of selected technologies in healthcare, based on the EUnetHTA Core Model and EUnetHTA / EMA join assessment procedure as well as capacity building and assessment.
Individual Stakeholders’ engagement and advocacy groups impact will be discussed in order to understand and anticipate the importance of formal regulatory framework as well as informal forces on utilization of value in healthcare and perception of value innovation in health technologies across all domains of HTA within EUnetHTA Core Model Concept.
Výstupy z učení
Completing the course, the student will gain deeper understanding and practical knowledge on different approaches towards Health Technology Assessment and Appraisal, with focus on EUnetHTA Core Model Process of Assessment and Appraisal as well as EUnetHTA / EMA Join assessment procedure. They will understand the roles, motivators and setbacks of different stakeholders (e.g. producers, regulators, payers, healthcare professionals, patients and patient advocacy groups, caregivers, health policy makers) in a process of value creation and utilization in healthcare for various products, services and technologies.
  • Selected Cases and methodologies from several resources as follows:
  • - EUnetHTA initiatives (JA1, JA2 and Collaboration);
  • - EUnetHTA Core Model;
  • - HTA Methodologies across the Globe (HTAi, INAHTA), EUnetHTA / EMA join assessment;
  • - Stakeholders Engagement;
  • - Patient Advocacy Groups and their interactions across and within the Healthcare Systems; EUPATI and European Patient Forum;
  • - CADTH and its specificities / soft-domains of HTA;
  • - NICE and SMC;
  • - G-BA and IQWiG;
  • - HAS and AIFA,
  • - HTA in Central & Eastern Europe;
  • - HTA in selected Asia-Pacific Regions; Global HTA initiatives.
    doporučená literatura
  • Value in Health, ISPOR.
  • International Journal of Technology Assessment in Healthcare, Cambridge University Press and HTAi.
  • Pharmacoeconomics :principles and practice. Edited by Lorenzo Pradelli - Albert Wertheimer. First edition. 1 online r. ISBN 9788897419389. info
  • J. Lyle Bootman. Principles of Pharmacoeconomics. info
  • Rascati, L. Karen. Essentials of Pharmacoeconomics. Philadelphia: Wolters Kluwer Health/Lippincott W, 2014. ISBN 978-1451175936. info
Výukové metody
Monological, Dialogic (discussion, interview, brainstorming) Workshops, Individual and Group Assignment / Presentations
Metody hodnocení
one individual and one group project assignment presentation
Vyučovací jazyk
Další komentáře
Předmět je vyučován každoročně.
Výuka probíhá každý týden.

  • Permalink: